Trials / Terminated
TerminatedNCT04106531
Validation of a Quality of Life Metric "Prolac-10"
Validation of a Novel Patient-Reported Quality of Life Metric "Prolac-10" for Patients Undergoing Medical Therapy for Prolactinoma
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (actual)
- Sponsor
- Ohio State University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a short-term validation study of a quality of life metric "Prolac-10" for patients diagnosed with a prolactinoma, undergoing new medical therapy.
Detailed description
This is a single-site validation study of a novel quality of life study for patients undergoing medical therapy for prolactinoma. Patients will be consented before starting their medical regimen and complete the "Prolac-10" questionnaire for baseline and will continued to be followed for 13-weeks into their medical care. The primary goal of this study is to validate the novel quality of life questionnaire in terms of sensitivity, repeatability, and consistency. Secondarily, we aim to validate the test-retest characteristics to further validate sensitivity, repeatability, and consistency. The Prolac-10 metric is Copyright © 2019. The Ohio State University. Modification/derivative rights reserved, all other rights available.
Conditions
- Prolactinoma
- Prolactin-Producing Pituitary Tumor
- Pituitary Tumor
- Prolactinoma Macroadenoma
- Prolactinoma Microadenoma
Timeline
- Start date
- 2019-10-15
- Primary completion
- 2023-06-13
- Completion
- 2023-06-13
- First posted
- 2019-09-27
- Last updated
- 2025-12-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04106531. Inclusion in this directory is not an endorsement.